Risk of non-melanoma skin cancer with biological therapy in common inflammatory diseases: a systemic review and meta-analysis

Overview of attention for article published in Cancer Cell International, November 2021

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#30 of 2,281)
High Attention Score compared to outputs of the same age (91st percentile)
High Attention Score compared to outputs of the same age and source (98th percentile)

Mentioned by

news: 2 news outlets

twitter: 8 X users

Citations

dimensions_citation: 13 Dimensions

Readers on

mendeley: 32 Mendeley

Summary News X Dimensions citations

So far, Altmetric has seen 9 X posts from 8 X users, with an upper bound of 10,033 followers.

#Risk of non-melanoma skin cancer with biological therapy in common inflammatory diseases: a systemic review and meta-analysis https://t.co/Xo7JGmM0Q7

29 Mar 2022

Reply Repost Favourite

Risk of non-melanoma skin cancer with biological therapy in common inflammatory diseases. https://t.co/d4ayLwjNv6

25 Nov 2021

Reply Repost Favourite

RT @ingentium_mel: Risk of non-melanoma skin cancer with biological therapy in common inflammatory diseases: a systemic review and meta-ana…

25 Nov 2021

Reply Repost Favourite

RT @ingentium_mel: Risk of non-melanoma skin cancer with biological therapy in common inflammatory diseases: a systemic review and meta-ana…

25 Nov 2021

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 5 additional X posts.